{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T10:36:47Z","timestamp":1792665407403,"version":"4.5.0"},"reference-count":119,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1097\/rlu.0000000000000985","type":"journal-article","created":{"date-parts":[[2015,10,8]],"date-time":"2015-10-08T12:12:19Z","timestamp":1444306339000},"page":"126-133","source":"Crossref","is-referenced-by-count":63,"title":["Sentinel Lymph Node Biopsy in Breast Cancer"],"prefix":"10.1097","volume":"41","author":[{"given":"Gianpiero","family":"Manca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Rubello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Tardelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Giammarile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Mazzarri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Boni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sotirios","family":"Chondrogiannis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Cristina","family":"Marzola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Chiacchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Ghilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Roncella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duccio","family":"Volterrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick M.","family":"Colletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-5-20210204","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/1097-0142(19890101)63:1<181::AID-CNCR2820630129>3.0.CO;2-H","article-title":"Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases.","volume":"63","author":"Carter","year":"1989","journal-title":"Cancer"},{"key":"R2-5-20210204","doi-asserted-by":"crossref","first-page":"122","DOI":"10.6004\/jnccn.2009.0012","article-title":"Breast cancer. Clinical practice guidelines in oncology.","volume":"7","author":"Carlson","year":"2009","journal-title":"J Natl Compr Canc Netw"},{"key":"R4-5-20210204","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1097\/00000658-199412000-00009","article-title":"The orderly progression of melanoma nodal metastases.","volume":"220","author":"Reintgen","year":"1994","journal-title":"Ann Surg"},{"key":"R5-5-20210204","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1056\/NEJMoa012782","article-title":"A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer.","volume":"349","author":"Veronesi","year":"2003","journal-title":"N Engl J Med"},{"key":"R6-5-20210204","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1200\/JCO.2013.54.1177","article-title":"Sentinel lymph node biopsy for patients with early-stage breast cancer: American Society of Clinical Oncology clinical practice guideline update.","volume":"32","author":"Lyman","year":"2014","journal-title":"J Clin Oncol"},{"key":"R7-5-20210204","doi-asserted-by":"crossref","first-page":"405","DOI":"10.2967\/jnumed.110.081711","article-title":"The sentinel node procedure in breast cancer: nuclear medicine as the starting point.","volume":"52","author":"Hindie","year":"2001","journal-title":"J Nucl Med"},{"key":"R8-5-20210204","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.maturitas.2011.02.006","article-title":"Sentinel lymph node biopsy indications and controversies in breast cancer.","volume":"69","author":"Wiatrek","year":"2011","journal-title":"Maturitas"},{"key":"R10-5-20210204","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1001\/jama.1996.03540220042028","article-title":"Lymphatic mapping and sentinel node biopsy in the patient with breast cancer.","volume":"276","author":"Albertini","year":"1996","journal-title":"JAMA"},{"key":"R11-5-20210204","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1146\/annurev.med.51.1.525","article-title":"Lymphatic mapping and sentinel lymph node biopsy in patients with breast cancer.","volume":"51","author":"Cox","year":"2000","journal-title":"Annu Rev Med"},{"key":"R12-5-20210204","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/cncr.21568","article-title":"Lymphatic mapping and sentinel lymph node biopsy in early-stage breast carcinoma: a metaanalysis.","volume":"106","author":"Kim","year":"2006","journal-title":"Cancer"},{"key":"R13-5-20210204","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s10549-006-9192-1","article-title":"Factors affecting failed localisation and false-negative rates of sentinel node biopsy in breast cancerresults of the ALMANAC validation phase.","volume":"99","author":"Goyal","year":"2006","journal-title":"Breast Cancer Res Treat"},{"key":"R14-5-20210204","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1007\/s00259-013-2544-2","article-title":"The EANM and SNMMI practice guideline for lymphoscintigraphy and sentinel node localization in breast cancer.","volume":"40","author":"Giammarile","year":"2013","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R15-5-20210204","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.eururo.2011.03.024","article-title":"Intraoperative laparoscopic fluorescence guidance to the sentinel lymph node in prostate cancer patients: clinical proof of concept of an integrated functional imaging approach using a multimodal tracer.","volume":"60","author":"van der Poel","year":"2011","journal-title":"Eur Urol"},{"key":"R16-5-20210204","first-page":"199","article-title":"Optical image-guided surgerywhere do we stand Mol Imaging Biol.","volume":"13","author":"Keereweer","year":"2011","journal-title":""},{"key":"R17-5-20210204","first-page":"193","article-title":"Hybrid tracers for sentinel node biopsy.","volume":"58","author":"Van Den Berg","year":"2014","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"R18-5-20210204","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1245\/s10434-013-2887-8","article-title":"Comparative evaluation of (99m)Tctilmanocept for sentinel lymph node mapping in breast cancer patients: results of two phase 3 trials.","volume":"20","author":"Wallace","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"R19-5-20210204","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1245\/s10434-013-3379-6","article-title":"Sentinel node biopsy using a magnetic tracer versus standard technique: the SentiMAG Multicentre Trial.","volume":"21","author":"Douek","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"R20-5-20210204","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.breast.2014.01.004","article-title":"The Central-European SentiMag study: sentinel lymph node biopsy with superparamagnetic iron oxide (SPIO) vs. radioisotope.","volume":"23","author":"Thill","year":"2014","journal-title":"Breast"},{"key":"R21-5-20210204","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1245\/s10434-007-9709-9","article-title":"The lymphatic anatomy of the breast and its implications for sentinel lymph node biopsy: a human cadaver study.","volume":"15","author":"Suami","year":"2008","journal-title":"Ann Surg Oncol"},{"key":"R22-5-20210204","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S1072-7515(00)00776-6","article-title":"Anatomy and physiology of lymphatic drainage of the breast from the perspective of sentinel node biopsy.","volume":"192","author":"Tanis","year":"2001","journal-title":"J Am Coll Surg"},{"key":"R23-5-20210204","first-page":"713","article-title":"Sentinel node biopsy in breast cancer in French.","volume":"96","author":"Hindie","year":"2009","journal-title":"Bull Cancer"},{"key":"R25-5-20210204","doi-asserted-by":"crossref","first-page":"3664","DOI":"10.1200\/JCO.2006.08.4228","article-title":"Prospective multicentric randomized study comparing periareolar and peritumoral injection of radiotracer and blue dye for the detection of sentinel lymph node in breast sparing procedures: FRANSENODE trial.","volume":"25","author":"Rodier","year":"2007","journal-title":"J Clin Oncol"},{"key":"R26-5-20210204","first-page":"1198","article-title":"Radioguided sentinel lymph node biopsy in breast cancer surgery.","volume":"42","author":"Mariani","year":"2001","journal-title":"J Nucl Med"},{"key":"R27-5-20210204","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s10549-014-2866-1","article-title":"Axillary concordance between superficial and deep sentinel node mapping material injections in breast cancer patients: systematic review and meta-analysis of the literature.","volume":"144","author":"Sadeghi","year":"2014","journal-title":"Breast Cancer Res Treat"},{"key":"R28-5-20210204","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1002\/cncr.10539","article-title":"Proceedings of the consensus conference on the role of sentinel lymph node biopsy in carcinoma of the breast, April 19-22, 2001, Philadelphia, Pennsylvania.","volume":"94","author":"Schwartz","year":"2002","journal-title":"Cancer"},{"key":"R29-5-20210204","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/1477-7819-3-64","article-title":"Using the intraoperative hand held probe without lymphoscintigraphy or using only dye correlates with higher sensory morbidity following sentinel lymph node biopsy in breast cancer: a review of the literature.","volume":"3","author":"Kim","year":"2005","journal-title":"World J Surg Oncol"},{"key":"R31-5-20210204","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/jso.20574","article-title":"Clinical implications of sentinel nodes outside the axilla and internal mammary chain in patients with breast cancer.","volume":"94","author":"van Rijk","year":"2006","journal-title":"J Surg Oncol"},{"key":"R32-5-20210204","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.ejca.2004.05.008","article-title":"Role of routine preoperative lymphoscintigraphy in sentinel node biopsy for breast cancer.","volume":"41","author":"Goyal","year":"2005","journal-title":"Eur J Cancer"},{"key":"R33-5-20210204","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S1072-7515(98)00011-8","article-title":"Sentinel lymph node biopsy in breast cancer: guidelines and pitfalls of lymphoscintigraphy and gamma probe detection.","volume":"186","author":"Borgstein","year":"1998","journal-title":"J Am Coll Surg"},{"key":"R34-5-20210204","first-page":"1232","article-title":"Nonvisualization of axillary sentinel node during lymphoscintigraphy: is there a pathologic significance in breast cancer J Nucl Med.","volume":"44","author":"Brenot-Rossi","year":"2003","journal-title":""},{"key":"R35-5-20210204","doi-asserted-by":"crossref","first-page":"7703","DOI":"10.1200\/JCO.2005.08.001","article-title":"American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer.","volume":"23","author":"Lyman","year":"2005","journal-title":"J Clin Oncol"},{"key":"R36-5-20210204","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/MNM.0b013e32835c5a24","article-title":"SPECTCT in sentinel node imaging.","volume":"34","author":"Wagner","year":"2013","journal-title":"Nucl Med Commun"},{"key":"R37-5-20210204","first-page":"127","article-title":"Contribution of SPECTCT imaging to radioguided sentinel lymph node biopsy in breast cancer, melanoma, and other solid cancers: from open and see to see and open.","volume":"58","author":"Valdes Olmos","year":"2014","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"R38-5-20210204","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/BF02967195","article-title":"Dye- and gamma probe-guided sentinel lymph node biopsy in breast cancer patients: using patent blue dye and technetium-99m-labeled human serum albumin.","volume":"7","author":"Tsugawa","year":"2000","journal-title":"Breast Cancer"},{"key":"R39-5-20210204","first-page":"12","article-title":"Will the true sentinel node please stand Ann Surg Oncol.","volume":"6","author":"Morton","year":"1999","journal-title":""},{"key":"R40-5-20210204","first-page":"514","article-title":"Will the true sentinel node please stand Ann Surg Oncol.","volume":"6","author":"Nathanson","year":"1999","journal-title":""},{"key":"R41-5-20210204","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1067\/msy.2000.108064","article-title":"2nd, Edwards MJ, Wong SL, et al. Practical guidelines for optimal gamma probe detection of sentinel lymph nodes in breast cancer: results of a multi-institutional study. For the University of Louisville Breast Cancer Study Group.","volume":"128","author":"Martin","year":"2000","journal-title":"Surgery"},{"key":"R42-5-20210204","first-page":"853","article-title":"Is it necessary to harvest additional lymph nodes after resection of the most radioactive sentinel lymph node in breast cancer J Am Coll Surg.","volume":"207","author":"Liu","year":"2008","journal-title":""},{"key":"R43-5-20210204","first-page":"192","article-title":"Sentinel lymph node biopsy for melanoma: how many radioactive nodes should be removed Ann Surg Oncol.","volume":"8","author":"McMasters","year":"2001","journal-title":""},{"key":"R44-5-20210204","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.2967\/jnumed.108.055350","article-title":"Optimal detection of sentinel lymph node metastases by intraoperative radioactive threshold and molecular analysis in patients with melanoma.","volume":"49","author":"Manca","year":"2008","journal-title":"J Nucl Med"},{"key":"R45-5-20210204","doi-asserted-by":"crossref","first-page":"700","DOI":"10.2967\/jnumed.109.071407","article-title":"A portable gamma-camera for intraoperative detection of sentinel nodes in the head and neck region.","volume":"51","author":"Vermeeren","year":"2010","journal-title":"J Nucl Med"},{"key":"R46-5-20210204","first-page":"140","article-title":"Contribution of perioperative imaging to radioguided surgery.","volume":"58","author":"Vidal-Sicart","year":"2014","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"R47-5-20210204","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00259-011-1951-5","article-title":"Changing paradigms in radioguided surgery and intraoperative imaging: the GOSTT concept.","volume":"39","author":"Zaknun","year":"2012","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R48-5-20210204","first-page":"207","article-title":"The GOSTT concept and hybrid mixedvirtualaugmented reality environment radioguided surgery.","volume":"58","author":"Valdes Olmos","year":"2014","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"R49-5-20210204","first-page":"309","article-title":"Is it useful to remove internal mammary nodes in operable breast cancer Eur J Surg Oncol.","volume":"1","author":"Lacour","year":"1987","journal-title":""},{"key":"R50-5-20210204","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/1097-0142(19810101)47:1<170::AID-CNCR2820470128>3.0.CO;2-C","article-title":"Inefficacy of internal mammary nodes dissection in breast cancer surgery.","volume":"47","author":"Veronesi","year":"1981","journal-title":"Cancer"},{"key":"R51-5-20210204","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/S0959-8049(99)00133-1","article-title":"The dissection of internal mammary nodes does not improve the survival of breast cancer patients. 30-year results of a randomised trial.","volume":"35","author":"Veronesi","year":"1999","journal-title":"Eur J Cancer"},{"key":"R52-5-20210204","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1002\/1097-0142(19850215)55:4<880::AID-CNCR2820550429>3.0.CO;2-4","article-title":"A controlled trial of extended radical mastectomy.","volume":"55","author":"Meier","year":"1985","journal-title":"Cancer"},{"key":"R53-5-20210204","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/1097-0142(19890101)63:1<188::AID-CNCR2820630130>3.0.CO;2-M","article-title":"A controlled trial of extended radical versus radical mastectomy. Ten-year results.","volume":"63","author":"Meier","year":"1989","journal-title":"Cancer"},{"key":"R54-5-20210204","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1007\/BF02032889","article-title":"Five-year results of a randomized clinical trial comparing modified radical mastectomy and extended radical mastectomy for stage II breast cancer.","volume":"24","author":"Morimoto","year":"1994","journal-title":"Surg Today"},{"key":"R55-5-20210204","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1245\/aso.2002.9.1.77","article-title":"Subareolar injection of 99mTc facilitates sentinel lymph node identification.","volume":"9","author":"Tuttle","year":"2002","journal-title":"Ann Surg Oncol"},{"key":"R56-5-20210204","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1016\/S0140-6736(14)60488-8","article-title":"Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials.","volume":"383","author":"McGale","year":"2014","journal-title":"Lancet"},{"key":"R57-5-20210204","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.canrad.2014.06.016","article-title":"Controversy about internal mammary chain irradiation in breast cancer in French.","volume":"18","author":"Hennequin","year":"2014","journal-title":"Cancer Radiother"},{"key":"R58-5-20210204","first-page":"114","article-title":"Sentinel lymph node mapping in breast cancer: a critical reappraisal of the internal mammary chain issue.","volume":"58","author":"Manca","year":"2014","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"R59-5-20210204","doi-asserted-by":"crossref","first-page":"3628","DOI":"10.1200\/JCO.2002.02.026","article-title":"Revision of the American Joint Committee on Cancer staging system for breast cancer.","volume":"20","author":"Singletary","year":"2002","journal-title":"J Clin Oncol"},{"key":"R60-5-20210204","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1245\/s10434-010-0985-4","article-title":"The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM.","volume":"17","author":"Edge","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"R61-5-20210204","first-page":"758","article-title":"Can the sentinel lymph node technique affect decisions to offer internal mammary chain irradiation Eur J Nucl Med Mol Imaging.","volume":"36","author":"Bourre","year":"2009","journal-title":""},{"key":"R62-5-20210204","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1245\/s10434-006-9230-6","article-title":"The impact on post-surgical treatment of sentinel lymph node biopsy of internal mammary lymph nodes in patients with breast cancer.","volume":"14","author":"Madsen","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"R63-5-20210204","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/00000658-200107000-00012","article-title":"Halsted revisited: internal mammary sentinel lymph node biopsy in breast cancer.","volume":"234","author":"van der Ent","year":"2001","journal-title":"Ann Surg"},{"key":"R64-5-20210204","first-page":"789","article-title":"Internal mammary sentinel nodes: ignore, irradiate or operate Eur J Cancer.","volume":"45","author":"Coombs","year":"2009","journal-title":""},{"key":"R65-5-20210204","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1093\/annonc\/mdn725","article-title":"High-resolution lymphoscintigraphy is essential for recognition of the significance of internal mammary nodes in breast cancer.","volume":"20","author":"Spillane","year":"2009","journal-title":"Ann Oncol"},{"key":"R66-5-20210204","doi-asserted-by":"crossref","first-page":"238","DOI":"10.7326\/0003-4819-152-1-201001050-00190","article-title":"Systematic review: comparative effectiveness of core-needle and open surgical biopsy to diagnose breast lesions.","volume":"152","author":"Bruening","year":"2010","journal-title":"Ann Intern Med"},{"key":"R67-5-20210204","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1148\/radiol.11102368","article-title":"Ductal carcinoma in situ at core-needle biopsy: meta-analysis of underestimation and predictors of invasive breast cancer.","volume":"260","author":"Brennan","year":"2011","journal-title":"Radiology"},{"key":"R68-5-20210204","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1093\/jnci\/djp482","article-title":"Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes.","volume":"102","author":"Virnig","year":"2010","journal-title":"J Natl Cancer Inst"},{"key":"R70-5-20210204","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1111\/cas.12381","article-title":"Incidence and prediction of invasive disease and nodal metastasis in preoperatively diagnosed ductal carcinoma in situ.","volume":"105","author":"Osako","year":"2014","journal-title":"Cancer Sci"},{"key":"R71-5-20210204","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1177\/000313481007600925","article-title":"The use of sentinel lymph node biopsy in ductal carcinoma in situ.","volume":"76","author":"Schneider","year":"2010","journal-title":"Am Surg"},{"key":"R72-5-20210204","first-page":"1202","article-title":"Organ and fetal absorbed dose estimates from 99mTc-sulfur colloid lymphoscintigraphy and sentinel node localization in breast cancer patients.","volume":"47","author":"Pandit-Taskar","year":"2006","journal-title":"J Nucl Med"},{"key":"R73-5-20210204","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/j.1524-4741.2008.00570.x","article-title":"Pregnancy-associated breast cancer patients can safely undergo lymphatic mapping.","volume":"14","author":"Khera","year":"2008","journal-title":"Breast J"},{"key":"R74-5-20210204","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s00259-009-1217-7","article-title":"Sentinel lymph node biopsy in pregnant patients with breast cancer.","volume":"37","author":"Gentilini","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R75-5-20210204","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1245\/s10434-014-3718-2","article-title":"Sentinel lymph node biopsy in pregnant women with breast cancer.","volume":"21","author":"Gropper","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"R76-5-20210204","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.ejso.2009.10.007","article-title":"Adverse reactions to patent blue V dye - The NEW START and ALMANAC experience.","volume":"36","author":"Barthelmes","year":"2010","journal-title":"Eur J Surg Oncol"},{"key":"R77-5-20210204","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.1016\/j.suronc.2010.10.002","article-title":"Anaphylactic response to blue dye during sentinel lymph node biopsy.","volume":"20","author":"Bezu","year":"2011","journal-title":"Surg Oncol"},{"key":"R78-5-20210204","first-page":"10","article-title":"Contraindications of sentinel lymph node biopsy: are there any really World J Surg Oncol.","volume":"5","author":"Filippakis","year":"2007","journal-title":""},{"issue":"Suppl 1","key":"R79-5-20210204","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1016\/S1743-9191(13)60020-5","article-title":"Management of breast cancer during pregnancy.","volume":"11","author":"Rovera","year":"2013","journal-title":"Int J Surg"},{"key":"R80-5-20210204","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.ejso.2006.02.018","article-title":"Sentinel lymph node biopsy in multicentric breast cancer. The experience of the European Institute of Oncology.","volume":"32","author":"Gentilini","year":"2006","journal-title":"Eur J Surg Oncol"},{"key":"R81-5-20210204","doi-asserted-by":"crossref","first-page":"3374","DOI":"10.1200\/JCO.2006.05.7372","article-title":"Multicentric breast cancer: a new indication for sentinel node biopsya multi-institutional validation study.","volume":"24","author":"Knauer","year":"2006","journal-title":"J Clin Oncol"},{"key":"R82-5-20210204","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1093\/annonc\/mdp586","article-title":"Feasibility of sentinel lymph node biopsy in multiple unilateral synchronous breast cancer: results of a French prospective multi-institutional study (IGASSU 0502).","volume":"21","author":"Giard","year":"2010","journal-title":"Ann Oncol"},{"key":"R83-5-20210204","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.ejso.2011.01.011","article-title":"Accuracy of sentinel lymph node biopsy in large and multifocalmulticentric breast carcinomaa systematic review.","volume":"37","author":"Spillane","year":"2011","journal-title":"Eur J Surg Oncol"},{"key":"R84-5-20210204","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1046\/j.0007-1323.2001.01948.x","article-title":"Multicentre study of detection and false-negative rates in sentinel node biopsy for breast cancer.","volume":"88","author":"Bergkvist","year":"2001","journal-title":"Br J Surg"},{"key":"R85-5-20210204","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.ejso.2005.09.001","article-title":"Results of sentinel node biopsy not affected by previous excisional biopsy.","volume":"32","author":"Heuts","year":"2006","journal-title":"Eur J Surg Oncol"},{"key":"R86-5-20210204","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1245\/ASO.2005.10.018","article-title":"Second biopsy of axillary sentinel lymph node for reappearing breast cancer after previous sentinel lymph node biopsy.","volume":"12","author":"Intra","year":"2005","journal-title":"Ann Surg Oncol"},{"key":"R87-5-20210204","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1245\/ASO.2006.12.002","article-title":"Lymphatic mapping and sentinel lymph node biopsy for patients with local recurrence after breast-conservation therapy.","volume":"13","author":"Newman","year":"2006","journal-title":"Ann Surg Oncol"},{"key":"R88-5-20210204","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1245\/s10434-009-0349-0","article-title":"Sentinel node biopsy in patients with previous breast aesthetic surgery.","volume":"16","author":"Rodriguez Fernandez","year":"2009","journal-title":"Ann Surg Oncol"},{"key":"R89-5-20210204","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1245\/s10434-006-9237-z","article-title":"Reoperative sentinel lymph node biopsy: a new frontier in the management of ipsilateral breast tumor recurrence.","volume":"14","author":"Port","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"R90-5-20210204","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1245\/ASO.2006.08.026","article-title":"Sentinel lymph node biopsy for local recurrence of breast cancer after breast-conserving therapy.","volume":"13","author":"Taback","year":"2006","journal-title":"Ann Surg Oncol"},{"key":"R91-5-20210204","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.breast.2009.09.009","article-title":"Reoperative sentinel lymph node biopsy in ipsilateral breast cancer relapse.","volume":"18","author":"Tasevski","year":"2009","journal-title":"Breast"},{"key":"R92-5-20210204","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1245\/s10434-010-1120-2","article-title":"Sentinel lymph node biopsy in patients with previous ipsilateral complete axillary lymph node dissection.","volume":"18","author":"Kaur","year":"2011","journal-title":"Ann Surg Oncol"},{"issue":"Suppl 3","key":"R93-5-20210204","doi-asserted-by":"crossref","first-page":"S90","DOI":"10.1016\/S0960-9776(09)70281-4","article-title":"Breast conservation and sentinel lymph node biopsy after neoadjuvant systemic therapy.","volume":"18","author":"Veronesi","year":"2009","journal-title":"Breast"},{"key":"R94-5-20210204","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/bjs.5209","article-title":"Meta-analysis of sentinel lymph node biopsy after preoperative chemotherapy in patients with breast cancer.","volume":"93","author":"Xing","year":"2006","journal-title":"Br J Surg"},{"key":"R95-5-20210204","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.acra.2009.01.026","article-title":"Breast cancer sentinel node identification and classification after neoadjuvant chemotherapy-systematic review and meta analysis.","volume":"16","author":"Kelly","year":"2009","journal-title":"Acad Radiol"},{"key":"R96-5-20210204","doi-asserted-by":"crossref","first-page":"3124","DOI":"10.1016\/j.ejca.2009.08.001","article-title":"Accuracy of sentinel node biopsy after neoadjuvant chemotherapy in breast cancer patients: a systematic review.","volume":"45","author":"van Deurzen","year":"2009","journal-title":"Eur J Cancer"},{"key":"R97-5-20210204","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/jso.21911","article-title":"The feasibility and accuracy of sentinel lymph node biopsy in clinically node-negative patients after neoadjuvant chemotherapy for breast cancera systematic review and meta-analysis.","volume":"104","author":"Tan","year":"2011","journal-title":"J Surg Oncol"},{"key":"R98-5-20210204","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1159\/000360411","article-title":"Local treatment of the axilla in early breast cancer: concepts from the national surgical adjuvant breast and bowel project B-04 to the planned intergroup sentinel mamma trial.","volume":"9","author":"Reimer","year":"2014","journal-title":"Breast Care (Basel)"},{"key":"R99-5-20210204","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S1470-2045(13)70166-9","article-title":"Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study.","volume":"14","author":"Kuehn","year":"2013","journal-title":"Lancet Oncol"},{"key":"R100-5-20210204","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1001\/jama.2013.278932","article-title":"Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial.","volume":"310","author":"Boughey","year":"2013","journal-title":"JAMA"},{"key":"R101-5-20210204","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1056\/NEJM199810013391401","article-title":"The sentinel node in breast cancera multicenter validation study.","volume":"339","author":"Krag","year":"1998","journal-title":"N Engl J Med"},{"key":"R102-5-20210204","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1200\/JCO.1997.15.6.2345","article-title":"Sentinel lymphadenectomy in breast cancer.","volume":"15","author":"Giuliano","year":"1997","journal-title":"J Clin Oncol"},{"key":"R103-5-20210204","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1016\/S0140-6736(97)01004-0","article-title":"Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes.","volume":"349","author":"Veronesi","year":"1997","journal-title":"Lancet"},{"key":"R104-5-20210204","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s10549-010-1210-7","article-title":"Safety of avoiding routine use of axillary dissection in early stage breast cancer: a systematic review.","volume":"125","author":"Pepels","year":"2011","journal-title":"Breast Cancer Res Treat"},{"key":"R105-5-20210204","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S1470-2045(06)70947-0","article-title":"Sentinel-lymph-node biopsy as a staging procedure in breast cancer: update of a randomised controlled study.","volume":"7","author":"Veronesi","year":"2006","journal-title":"Lancet Oncol"},{"key":"R106-5-20210204","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S1470-2045(07)70278-4","article-title":"Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial.","volume":"8","author":"Krag","year":"2007","journal-title":"Lancet Oncol"},{"key":"R107-5-20210204","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1097\/SLA.0b013e3182654494","article-title":"Factors associated with local-regional recurrence after a negative sentinel node dissection: results of the ACOSOG Z0010 trial.","volume":"256","author":"Hunt","year":"2012","journal-title":"Ann Surg"},{"key":"R108-5-20210204","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1056\/NEJMoa1008108","article-title":"Effect of occult metastases on survival in node-negative breast cancer.","volume":"364","author":"Weaver","year":"2011","journal-title":"N Engl J Med"},{"key":"R109-5-20210204","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1001\/jama.2011.90","article-title":"Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial.","volume":"305","author":"Giuliano","year":"2011","journal-title":"JAMA"},{"key":"R111-5-20210204","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S1470-2045(13)70035-4","article-title":"Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial.","volume":"14","author":"Galimberti","year":"2013","journal-title":"Lancet Oncol"},{"key":"R112-5-20210204","doi-asserted-by":"crossref","first-page":"3144","DOI":"10.1245\/s10434-012-2531-z","article-title":"American College of Surgeons Oncology Group (ACOSOG) Z0011: impact on surgeon practice patterns.","volume":"19","author":"Caudle","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"R113-5-20210204","first-page":"95","article-title":"Long-term clinical impact of sentinel lymph node biopsy in breast cancer and cutaneous melanoma.","volume":"58","author":"Gangi","year":"2014","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"R114-5-20210204","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.ijsu.2009.04.012","article-title":"Sentinel lymph node biopsy after neoadjuvant chemotherapy in inflammatory breast cancer.","volume":"7","author":"Hidar","year":"2009","journal-title":"Int J Surg"},{"key":"R115-5-20210204","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/BF02967528","article-title":"Adjuvant therapy for breast cancerresults from the USA consensus conference.","volume":"8","author":"Abrams","year":"2001","journal-title":"Breast Cancer"},{"key":"R116-5-20210204","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1093\/jnci\/90.21.1601","article-title":"Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer.","volume":"90","author":"Goldhirsch","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"R117-5-20210204","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1056\/NEJMoa021967","article-title":"A gene-expression signature as a predictor of survival in breast cancer.","volume":"347","author":"van de Vijver","year":"2002","journal-title":"N Engl J Med"},{"key":"R118-5-20210204","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S1470-2045(09)70314-6","article-title":"Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial.","volume":"11","author":"Albain","year":"2010","journal-title":"Lancet Oncol"},{"key":"R119-5-20210204","doi-asserted-by":"crossref","first-page":"3726","DOI":"10.1200\/JCO.2005.04.7985","article-title":"Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer.","volume":"24","author":"Paik","year":"2006","journal-title":"J Clin Oncol"},{"key":"R120-5-20210204","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/S1470-2045(14)70460-7","article-title":"Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial.","volume":"15","author":"Donker","year":"2014","journal-title":"Lancet Oncol"},{"key":"R121-5-20210204","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1016\/S0959-8049(03)00203-X","article-title":"Pathological work-up of sentinel lymph nodes in breast cancer. Review of current data to be considered for the formulation of guidelines.","volume":"39","author":"Cserni","year":"2003","journal-title":"Eur J Cancer"},{"key":"R122-5-20210204","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1093\/annonc\/mdr304","article-title":"Strategies for subtypesdealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011.","volume":"22","author":"Goldhirsch","year":"2011","journal-title":"Ann Oncol"},{"key":"R123-5-20210204","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.ejso.2004.02.009","article-title":"Sentinel lymph node biopsy in patients with multifocal breast cancer.","volume":"30","author":"Goyal","year":"2004","journal-title":"Eur J Surg Oncol"},{"key":"R124-5-20210204","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1245\/s10434-011-2108-2","article-title":"Recommendations from an international consensus conference on the current status and future of neoadjuvant systemic therapy in primary breast cancer.","volume":"19","author":"Kaufmann","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"R125-5-20210204","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1245\/s10434-008-0195-5","article-title":"Patterns of axillary surgical care for breast cancer in the era of sentinel lymph node biopsy.","volume":"16","author":"Rescigno","year":"2009","journal-title":"Ann Surg Oncol"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000000985","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T06:13:23Z","timestamp":1620972803000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003072-201602000-00005"}},"subtitle":["Indications, Contraindications, and Controversies"],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":119,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000000985","relation":{},"ISSN":["0363-9762"],"issn-type":[{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]}}}